Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

"Clinically proven" claims require strict testing and adherence to guidelines for trust and authenticity.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

The editorial concludes that while evidence-based medicine is crucial, doctors should also use their own experience and consider patient preferences in dermatology care.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

5% minoxidil works better for hair growth and density, with minor irritation.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Minoxidil lowers blood pressure effectively but may cause unwanted hair growth and other side effects.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.